Align Technology, Inc. (ALGN)
ALGN Stock Price Chart
Explore Align Technology, Inc. interactive price chart. Choose custom timeframes to analyze ALGN price movements and trends.
ALGN Company Profile
Discover essential business fundamentals and corporate details for Align Technology, Inc. (ALGN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
30 Jan 2001
Employees
21.20k
Website
https://www.aligntech.comCEO
Joseph Hogan
Description
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
ALGN Financial Timeline
Browse a chronological timeline of Align Technology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Jul 2026
EPS estimate is $2.62, while revenue estimate is $1.05bn.
Earnings released on 29 Apr 2026
EPS came in at $2.58 surpassing the estimated $2.30 by +12.17%, while revenue for the quarter reached $1.04bn , beating expectations by +1.84%.
Earnings released on 4 Feb 2026
EPS came in at $3.29 surpassing the estimated $2.99 by +10.03%, while revenue for the quarter reached $1.05bn , beating expectations by +1.41%.
Earnings released on 29 Oct 2025
EPS came in at $2.61 surpassing the estimated $2.40 by +8.75%, while revenue for the quarter reached $995.69m , beating expectations by +1.98%.
Earnings released on 30 Jul 2025
EPS came in at $2.49 falling short of the estimated $2.57 by -3.11%, while revenue for the quarter reached $1.01bn , missing expectations by -0.94%.
Earnings released on 30 Apr 2025
EPS came in at $2.13 surpassing the estimated $1.99 by +7.04%, while revenue for the quarter reached $979.26m , beating expectations by +0.41%.
Earnings released on 5 Feb 2025
EPS came in at $2.44 surpassing the estimated $2.43 by +0.41%, while revenue for the quarter reached $995.22m , missing expectations by -0.39%.
Earnings released on 23 Oct 2024
EPS came in at $2.35 surpassing the estimated $2.31 by +1.73%, while revenue for the quarter reached $977.87m , missing expectations by -1.23%.
Earnings released on 24 Jul 2024
EPS came in at $2.41 surpassing the estimated $2.34 by +2.99%, while revenue for the quarter reached $1.03bn , missing expectations by -0.89%.
Earnings released on 24 Apr 2024
EPS came in at $2.14 surpassing the estimated $1.97 by +8.63%, while revenue for the quarter reached $997.43m , beating expectations by +2.35%.
Earnings released on 31 Jan 2024
EPS came in at $2.42 surpassing the estimated $2.18 by +11.01%, while revenue for the quarter reached $956.73m , beating expectations by +2.59%.
Earnings released on 25 Oct 2023
EPS came in at $2.14 falling short of the estimated $2.26 by -5.31%, while revenue for the quarter reached $960.21m , missing expectations by -3.64%.
Earnings released on 26 Jul 2023
EPS came in at $2.22 surpassing the estimated $2.02 by +9.90%, while revenue for the quarter reached $1.00bn , beating expectations by +1.07%.
Earnings released on 26 Apr 2023
EPS came in at $1.82 surpassing the estimated $1.69 by +7.69%, while revenue for the quarter reached $943.15m , beating expectations by +4.42%.
Earnings released on 1 Feb 2023
EPS came in at $1.73 surpassing the estimated $1.52 by +13.82%, while revenue for the quarter reached $901.52m , beating expectations by +1.09%.
Earnings released on 26 Oct 2022
EPS came in at $1.36 falling short of the estimated $2.21 by -38.46%, while revenue for the quarter reached $890.35m , missing expectations by -7.62%.
Earnings released on 27 Jul 2022
EPS came in at $2.00 falling short of the estimated $2.12 by -5.66%, while revenue for the quarter reached $969.55m , missing expectations by -1.53%.
Earnings released on 27 Apr 2022
EPS came in at $2.13 falling short of the estimated $2.22 by -4.05%, while revenue for the quarter reached $973.22m , missing expectations by -2.87%.
Earnings released on 2 Feb 2022
EPS came in at $2.83 surpassing the estimated $2.71 by +4.43%, while revenue for the quarter reached $1.03bn , beating expectations by +0.76%.
Earnings released on 27 Oct 2021
EPS came in at $2.87 surpassing the estimated $2.60 by +10.38%, while revenue for the quarter reached $1.02bn , beating expectations by +3.63%.
Earnings released on 28 Jul 2021
EPS came in at $3.04 surpassing the estimated $2.53 by +20.16%, while revenue for the quarter reached $1.01bn , beating expectations by +3.11%.
ALGN Stock Performance
Access detailed ALGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
